Schedule 13G ownership disclosure
VIVOS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 92859E207
Event date: 2024-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- V-CO Investors LLC
Shares: 514,498.00 · Class: 9.9%
- SP Manager LLC
Shares: 514,498.00 · Class: 9.9%
- Michael Skaff
Shares: 514,498.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002049575-24-000001
- Form type
- SCHEDULE 13G
- Filer
- V-CO Investors LLC
- CIK
- CIK 2049575
- Filed
- Dec 20, 2024
- Reporting period
- Dec 17, 2024
- Description
- Schedule 13G beneficial ownership